Evidence map›Paper›PMID 33883465›Full record

ArticleJournal of the Chinese Medical Association : JCMA2021

Hepatoma upregulated protein and Ki-67 expression in resectable hepatocellular carcinoma.

Hoa-Jan Lei, Sheng-Yu Wang, Ivy Yenwen Chau, Anna Fen-Yau Li, Yat-Pang Chau, Cheng-Yuan Hsia, Shu-Cheng Chou, Yi-Chu Kao, Gar-Yang Chau

Open access · hybridAbstract read
In one paragraph

Article in Journal of the Chinese Medical Association : JCMA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Diffusion-based virtual MR elastography for predicting recurrence of solitary hepatocellular carcinoma after hepatectomy.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hoa-Jan LeiDepartment of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Sheng-Yu WangDepartment of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Ivy Yenwen ChauDepartment of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Anna Fen-Yau LiSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Yat-Pang ChauDepartment of Medicine, Mackay Medical College, New Taipei City, Taiwan, ROC.
Cheng-Yuan HsiaDepartment of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Shu-Cheng ChouDepartment of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Yi-Chu KaoDepartment of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Gar-Yang ChauDepartment of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
National Yang Ming Chiao Tung University · TWTaipei Veterans General Hospital · TWMackay Medical College · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatoma upregulated protein (HURP) and Ki-67 have been identified as cancer-related genes involved in cell growth and proliferation. Previous experimental studies have suggested an essential role for HURP expression in liver carcinogenesis. However, data regarding HURP expression in hepatocellular carcinoma (HCC) and its correlation with patient outcomes are limited. In this study, we examined the clinicopathologic features associated with HURP expression in HCC, and compared them to the results of the Ki-67 study.

methodsEighty-seven resected HCC at tumor, node, metastasis (TNM) stages I (n = 28), II (n = 29), and III (n = 30) were evaluated. HURP and Ki-67 expression were assessed by immunohistochemistry. Multivariate analysis was used to examine the prognostic significance of HURP and Ki-67 expression.

resultsHURP expression in HCC tissue was observed in 59% of patients and associated with female sex, low white blood cell count, and low platelet count. Ki-67 expression was observed in 67% of patients and associated with younger age, higher serum α-fetoprotein (AFP) levels, and frequent microvascular invasion. Univariate analysis showed that factors related to overall survival were: age >55 years, AFP >20 ng/mL, indocyanine green retention rate at 15 minutes (ICG-15) >15%, tumor size >5 cm, multiple tumors, macrovascular invasion, microvascular invasion, Ki-67 expression, and serum vascular endothelial growth factor >170 pg/mL. HURP expression was not associated with postresection survival. Multivariate analysis indicated that macrovascular invasion, multiple tumors, ICG-15 >15%, and Ki-67 expression were independent factors for overall survival. Multiple tumors and Ki-67 expression were independent factors related to recurrence-free survival.

conclusionIn our study, HURP expression in HCC tissue was not associated with post-resection survival. Ki-67 expression was an independent prognostic factor for survival. Our results suggest that the effect of HURP activity on growth, invasion, and postresection outcome of HCC in actual patients is less than previously demonstrated in experimental studies.

Indexed as

Carcinoma, HepatocellularCell ProliferationFemaleFlow CytometryHumansImmunohistochemistryKi-67 AntigenMaleMiddle AgedNeoplasm ProteinsPrognosisProspective StudiesSurvival AnalysisDLGAP5 protein, humanKi-67 AntigenNeoplasm Proteins

Identifiers

PMID33883465
PMCPMC12966124
OpenAlexW3156528858

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.